Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-019091
Filing Date
2024-04-10
Accepted
2024-04-10 16:05:48
Documents
6
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20020406x1_def14.htm DEF 14A 1221732
2 ny20020406x1_barchart01.jpg GRAPHIC 198357
3 ny20020406x1_barchart02.jpg GRAPHIC 205485
4 sig_franktortimd.jpg GRAPHIC 19045
5 ny20020406x1_pc01.jpg GRAPHIC 716981
6 ny20020406x1_pc02.jpg GRAPHIC 555879
  Complete submission text file 0001140361-24-019091.txt   3557130
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34949 | Film No.: 24835793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)